Eurasian Journal of Biosciences

Study the relationship between Interleukin-35 and clusterin with Mda, Gsh, Cat and Sod among male Iraqi chronic Hepatitis C patients


Background: Chronic Hepatitis C (CHC) disease is known as a main public health problem through the world. CHC disease might lead to fibrosis of hepatocytes. In present paper, we attempted to measure whether there is any association among IL-35 and CLU with MAD, GSH, CAT and SOD, and several biochemical variables such as AST, ALT, GGT, ALP, T. BIL, and albumin. Methods: This study has included 44 patients from the Al-Fallujah Teaching Hospital, who was having CHC disease, and 44 healthy controls (HCs) were registered. Serum AST, ALT, GGT, ALP, T. BIL, albumin concentrations were estimated by colorimetric methods, IL-35 and CLU, MAD, GSH, CAT and SOD levels were estimated by ELISA technique. Results: Compared with healthy controls, the serum IL-35 and CLU, GSH, CAT and SOD concentrations were lower of patients with CHC and the serum MDA values were higher (P<0.0001, all), the serum IL-35 and CLU concentrations related positively with serum GSH, CAT, SOD and albumin, and negatively correlated with MDA, AST, ALT, GGT, ALP and T. BIL concentrations (all P<0.01). The area under the receiver operating characteristic (AUROC) curve of serum for MDA, CLU, SOD, CAT, IL-35 and GSH levels were 0.9904, 0.9403, 0.9274, 0.9246, 0.8515 and 0.82, respectively. Conclusion: Correlation among IL-35 and CLU with MAD, GSH, CAT and SOD may be attractive markers to predict disease development in CHC patients.


  • Abd El-Latef, T. M., Hamed, E. O., Fahem, K. Y., & Mahmoud, A. S. (2019). Serum Clusterin as a Diagnostic Tool for HCV Related Hepatocellular Carcinoma. The Medical Journal of Cairo University, 87(March), 27-32.
  • Avery, S. V. (2011). Molecular targets of oxidative stress. Biochemical Journal, 434(2), 201-210.
  • Barbaro, G., Di Lorenzo, G., Asti, A., Ribersani, M., Belloni, G., Grisorio, B., ... & Barbarini, G. (1999). Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. The American journal of gastroenterology, 94(8), 2198-2205.
  • Bartsch, H., & Nair, J. (2006). Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbeck’s Archives of Surgery, 391(5), 499-510.
  • Baumert T.F, Juhling F. & Ono A. (2017). Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals. BMC Med. 15(1), 52-52.
  • Chrobot, A. M., Szaflarska-Szczepanik, A., & Drewa, G. (2000). Antioxidant defense in children with chronic viral hepatitis B and C. Medical Science Monitor, 6(4), 713-718.
  • Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., ... & Vignali, D. A. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450(7169), 566-569.
  • De Maria, N., Colantonl, A., Fagiuoli, S., Liu, G. J., Rogers, B. K., Farinati, F., ... & Floyd, R. A. (1996). Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radical Biology and Medicine, 21(3), 291-295.
  • El-Kannishy G, Arafa M and Abdelaal I, (2012). Persistent oxidative stress in patients with chronic active hepatitis-C infection after antiviral therapy failure. Saudi J Gastroenterol. 18, 375-9.
  • Farinati, F., Cardin, R., Degan, P., De Maria, N., Floyd, R. A., Van Thiel, D. H., & Naccarato, R. (1999). Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radical Biology and Medicine, 27(11-12), 1284-1291.
  • Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004). Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology, 127(5), S35-S50.
  • Fujinaga, H., Tsutsumi, T., Yotsuyanagi, H., Moriya, K., & Koike, K. (2011). Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology, 81(Suppl. 1), 11-17.
  • Houghton, M. (2019). Hepatitis C Virus: 30 Years after Its Discovery. Cold Spring Harbor Perspectives in Medicine, 9(12), a037069.
  • Huang, H., Chen, Y., & Ye, J. (2007). Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. Proceedings of the National Academy of Sciences, 104(47), 18666-18670.
  • Kang, Y. K., Hong, S. W., Lee, H., & Kim, W. H. (2004). Overexpression of clusterin in human hepatocellular carcinoma. Human pathology, 35(11), 1340-1346.
  • Kodydková, J., Vávrová, L., Kocík, M., & Zak, A. (2014). Human catalase, its polymorphisms, regulation and changes of its activity in different diseases. Folia biologica, 60(4), 153.
  • Li, X., Tian, L., and Dong, Y. (2015). IL-35 inhibits HBV antigen-specific IFNγ -producing CTLs in vitro. Clin.Sci.129, 395–404..
  • Liu, S., Zhang, Q., Shao, X., Wang, W., Zhang, C., & Jin, Z. (2017). An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection. International Immunopharmacology, 50, 87-94.
  • Long, J., Zhang, X., Wen, M., Kong, Q., Lv, Z., An, Y., & Wei, X. Q. (2013). IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochemical and biophysical research communications, 430(1), 364-369.
  • Mokhtari, E., Khamehchian, M., Montazer, G., & Nikudel, M. (2016). Landfill Site Selection Using Simple Additive Weighting (SAW) Method and Artificial Neural Network Method; A Case Study from Lorestan Province, Iran. International Journal of Geography and Geology, 5(10), 209-223.
  • Moosavy, S. H., Davoodian, P., Nazarnezhad, M. A., Nejatizaheh, A., Eftekhar, E., & Mahboobi, H. (2017). Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection. Electronic physician, 9(10), 5646.
  • Nakhjavani, M., Mashayekh, A., Khalilzadeh, O., Asgarani, F., Morteza, A., Omidi, M., & Froutan, H. (2011). Oxidized low-density lipoprotein is associated with viral load and disease activity in patients with chronic hepatitis C. Clinics and research in hepatology and gastroenterology, 35(2), 111-116.
  • Osman, H. G., Gabr, O. M., Lotfy, S., & Gabr, S. (2007). Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. Indian journal of medical microbiology, 25(4), 323.
  • Ramakrishnan, G., Raghavendran, H. R. B., Vinodhkumar, R., & Devaki, T. (2006). Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chemico-biological interactions, 161(2), 104-114.
  • Rigoulet, M., Yoboue, E. D., & Devin, A. (2011). Mitochondrial ROS generation and its regulation: mechanisms involved in H2O2 signaling. Antioxidants & redox signaling, 14(3), 459-468.
  • Sansanwal, P., Li, L., & Sarwal, M. M. (2015). Inhibition of intracellular clusterin attenuates cell death in nephropathic cystinosis. Journal of the American Society of Nephrology, 26(3), 612-625.
  • Sevastianos, V. A., Voulgaris, T. A., & Dourakis, S. P. (2020). Hepatitis C, systemic inflammation and oxidative stress: correlations with metabolic diseases. Expert Review of Gastroenterology & Hepatology, 14(1), 27-37.
  • Shaban, N. Z., Helmy, M. H., El-Kersh, M. A., & Mahmoud, B. F. (2003). Effects of Bacillus thuringiensis toxin on hepatic lipid peroxidation and free-radical scavengers in rats given alpha-tocopherol or acetylsalicylate. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 135(4), 405-414.
  • Suzuki, Y., Imai, K., Takai, K., Hanai, T., Hayashi, H., Naiki, T., ... & Moriwaki, H. (2013). Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test. Journal of cancer research and clinical oncology, 139(5), 845-852.
  • Teng, D. K., Liu, Y., Lv, Y. F., Wang, L., Zhang, W., Wang, J. P., & Li, Y. (2019). Elevated interleukin-35 suppresses liver inflammation by regulation of T helper 17 cells in acute hepatitis B virus infection. International immunopharmacology, 70, 252-259.
  • Trevisani, F., Caraceni, P., Simoncini, M., Micati, M., Domenicali, M., Dazzani, F., ... & Guarnieri, C. (2002). Evidence of oxidative imbalance in long-term liver transplant patients. Digestive and Liver Disease, 34(4), 279-284.
  • Wang, Y., Liu, Y. H., Mai, S. J., He, L. J., Liao, Y. J., Deng, H. X., ... & Xie, D. (2010). Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. Journal of gastroenterology and hepatology, 25(6), 1123-1128.
  • Wisniewska-Ligier, M., Wozniakowska-Gesicka, T., & Lewkowicz, P., (2004). Neutrophil oxidative metabolism in children with chronic hepatitis C. Przegl Lek, 61, 1338-1341.
  • Xiang, X. G., & Xie, Q. (2015). IL‐35: a potential therapeutic target for controlling hepatitis B virus infection. Journal of digestive diseases, 16(1), 1-6.
  • Yamane, D., McGivern, D. R., Wauthier, E., Yi, M., Madden, V. J., Welsch, C., ... & Widman, D. G. (2014). Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nature medicine, 20(8), 927-935.
  • Zhang, J., Zhang, Y., Wang, Q., Li, C., Deng, H., Si, C., & Xiong, H. (2019). Interleukin‐35 in immune‐related diseases: protection or destruction. Immunology, 157(1), 13-20.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.